Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines

被引:131
作者
Schmoecker, Christoph
Weylandt, Karsten H.
Kahlke, Lena
Wang, Jingdong
Lobeck, Hartmut
Tiegs, Gisa
Berg, Thomas
Kang, Jing X.
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Univ Med Berlin, Charite, Dept Gastroenterol & Hepatol, Berlin, Germany
[4] Klinikum Ernst Von Bergmann, Dept Pathol, Potsdam, Germany
[5] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-8520 Erlangen, Germany
关键词
D O I
10.1002/hep.21626
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cytokines such os tumor necrosis factor alpha (TNF-alpha) are key factors in liver inflammation. M has been Supplementation with essential omega-3 polyunsatrated fatty acids (n-3 PUFA) demonstrated to lower TNF-alpha and IL-1 production in mononuclear cells. An inflammation-dampening effect has been observed with increased omega-3 fatty acid supplementation in several inflammatory diseases. In this study, we used the transgenic fat-1 mouse, expressing a Caenorhabdits elegans desaturase endogenously forming n-3 PUFA from n-6 PUFA, to analyze the effect of an increased n-3 PUFA tissue status in the macrophage-dependent acute D-galactosamine/lipopolysaccaride (D-GaIN/LPS) hepatitis model. We show less severe inflammatory liver injury in fat-1 mice with a balanced n-6/n-3 PUFA ratio as evidenced by reduced serum alanine aminotransferase levels and less severe histological liver damage. This decreased inflammatory response was associated with decreased plasma TNF-alpha levels and with reduced hepatic gene expression of TNF-alpha, IL-1 beta, IFN-gamma and IL-6 in fat-1 mice, leading to a decreased rate of apoptosis in livers from fat-1 animals, as measured by DAPI-staining. Conclusion: The results of this study offer evidence for an inflammation dampening effect of omega-3 polyunsaturated fatty acids in the context of liver inflammation.
引用
收藏
页码:864 / 869
页数:6
相关论文
共 50 条
[11]   OMEGA-3 FATTY ACIDS AND STRES [J].
Petrov, G. ;
Peikova, L. ;
Obreshkova, D. ;
Bojkova, M. ;
Tsvetkova, B. .
PHARMACIA, 2013, 60 (02) :16-20
[12]   Omega-3 fatty acids and inflammation [J].
Mori T.A. ;
Beilin L.J. .
Current Atherosclerosis Reports, 2004, 6 (6) :461-467
[13]   Omega-3 fatty acids and anorexia [J].
Goncalves, CG ;
Ramos, EJB ;
Suzuki, S ;
Meguid, MM .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (04) :403-407
[14]   Omega-3 fatty acids in cancer [J].
Laviano, Alessandro ;
Rianda, Serena ;
Molfino, Alessio ;
Rossi Fanelli, Filippo .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (02) :156-161
[15]   Immunomodulation by omega-3 fatty acids [J].
Calder, Philip C. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2007, 77 (5-6) :327-335
[16]   Omega-3 polyunsaturated fatty acids [J].
Forse, RA ;
Chavali, SR .
IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL II, PTS 1 AND 2, 1996, :906-911
[17]   Challenge of omega-3 fatty acids [J].
Melville, NA .
FOOD TECHNOLOGY, 2004, 58 (09) :56-+
[18]   Omega-3 fatty acids in psychiatry [J].
Severus, WE ;
Ahrens, B .
NERVENARZT, 2000, 71 (01) :58-62
[19]   Omega-3 fatty acids and dementia [J].
Cole, Greg M. ;
Ma, Qiu-Lan ;
Frautschy, Sally A. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2009, 81 (2-3) :213-221
[20]   Omega-3 essential fatty acids [J].
Pepping, J .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (08) :719-+